Hovig E - Search Results

1

Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer.

Dørum A, Heimdal K, Hovig E, Inganäs M, Møller P. Dørum A, et al. Among authors: hovig e. Am J Hum Genet. 1999 Sep;65(3):671-9. doi: 10.1086/302530. Am J Hum Genet. 1999. PMID: 10441573 Free PMC article.

2

Screening for germ line TP53 mutations in breast cancer patients.

Børresen AL, Andersen TI, Garber J, Barbier-Piraux N, Thorlacius S, Eyfjörd J, Ottestad L, Smith-Sørensen B, Hovig E, Malkin D, et al. Børresen AL, et al. Among authors: hovig e. Cancer Res. 1992 Jun 1;52(11):3234-6. Cancer Res. 1992. PMID: 1591732

3

A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing.

Dørum A, Møller P, Kamsteeg EJ, Scheffer H, Burton M, Heimdal KR, Maehle LO, Hovig E, Tropé CG, van der Hout AH, van der Meulen MA, Buys CH, te Meerman GJ. Dørum A, et al. Among authors: hovig e. Eur J Cancer. 1997 Dec;33(14):2390-2. doi: 10.1016/s0959-8049(97)00328-6. Eur J Cancer. 1997. PMID: 9616287

4

Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA.

Dørum A, Hovig E, Tropé C, Inganas M, Møller P. Dørum A, et al. Among authors: hovig e. Eur J Cancer. 1999 May;35(5):779-81. doi: 10.1016/s0959-8049(99)00050-7. Eur J Cancer. 1999. PMID: 10505039

5

BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.

Borg A, Dørum A, Heimdal K, Maehle L, Hovig E, Møller P. Borg A, et al. Among authors: hovig e. Dis Markers. 1999 Oct;15(1-3):79-84. doi: 10.1155/1999/278269. Dis Markers. 1999. PMID: 10595257 Free PMC article.

6

The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series.

Møller P, Borg A, Heimdal K, Apold J, Vallon-Christersson J, Hovig E, Maehle L; Norwegian Inherited Breast Cancer Group; Norwegian Inherited Ovarian Cancer Group. Møller P, et al. Among authors: hovig e. Eur J Cancer. 2001 May;37(8):1027-32. doi: 10.1016/s0959-8049(01)00075-2. Eur J Cancer. 2001. PMID: 11334729

7

Genetic epidemiology of BRCA1 mutations in Norway.

Møller P, Heimdal K, Apold J, Fredriksen A, Borg A, Hovig E, Hagen A, Hagen B, Pedersen JC, Maehle L; Norwegian Inherited Breast Cancer Group; Norwegian Inherited Ovarian Cancer Group. Møller P, et al. Among authors: hovig e. Eur J Cancer. 2001 Dec;37(18):2428-34. doi: 10.1016/s0959-8049(01)00299-4. Eur J Cancer. 2001. PMID: 11720839

8

Associations between gene expressions in breast cancer and patient survival.

Jenssen TK, Kuo WP, Stokke T, Hovig E. Jenssen TK, et al. Among authors: hovig e. Hum Genet. 2002 Oct;111(4-5):411-20. doi: 10.1007/s00439-002-0804-5. Epub 2002 Aug 23. Hum Genet. 2002. PMID: 12384785

9

Determination of hereditary mutations in the BRCA1 gene using archived serum samples and capillary electrophoresis.

Ekstrøm PO, Bjørge T, Dørum A, Longva AS, Heintz KM, Warren DJ, Hansen S, Gislefoss RE, Hovig E. Ekstrøm PO, et al. Among authors: hovig e. Anal Chem. 2004 Aug 1;76(15):4406-9. doi: 10.1021/ac049788k. Anal Chem. 2004. PMID: 15283579

10

BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study.

Bjørge T, Lie AK, Hovig E, Gislefoss RE, Hansen S, Jellum E, Langseth H, Nustad K, Tropé CG, Dørum A. Bjørge T, et al. Among authors: hovig e. Br J Cancer. 2004 Nov 15;91(10):1829-34. doi: 10.1038/sj.bjc.6602199. Br J Cancer. 2004. PMID: 15477862 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters